According to Grandview Research, the market for hybrid and decentralized clinical trials (DCTs) is projected to exceed $12 billion by 2030. To prepare for this influx, sponsors and CROs are leveraging insights gained from ongoing DCTs to formulate novel approaches that ensure sustainable, replicable, and efficient clinical practices. These strategies aim to empower entities to establish and nurture partnerships, utilize historical trial data to expedite the research pace, and simplify the daily operations for research sites and participants.
To materialize this vision, however, organizations must first identify their intrinsic strengths, collaborate on strategies with partners, and implement an integrated trial platform that serves as a custodian of data, an analytical tool, and a launchpad for core trial solutions including consent procedures, COAs, sensors, and more.
In this webinar, topic experts from Medable—namely, Sam Bavery (Vice President, Strategy & Growth), Paul O’Malley (Lead, Growth & Strategy), and Claire Marsden (Senior Vice President, Project Management)—delve into methods through which sponsors and CROs can elevate their trial execution to the next tier, aligning with their overarching organizational objectives.